Pediatric Acute Lymphoblastic Leukemia
Most common childhood cancer. Cure rates exceed 85% with multi-agent chemotherapy; CAR-T for refractory cases.
No Clinical Trials found for this cancer type.
Most common childhood cancer. Cure rates exceed 85% with multi-agent chemotherapy; CAR-T for refractory cases.
No Clinical Trials found for this cancer type.